XML 10 R2.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 48,504 $ 75,967
Restricted cash 9,922 3,967
Accounts receivable 5,589 9,935
Real estate inventory 256,472 276,500
Prepaid expenses and other current assets 2,553 5,236
Total current assets 323,040 371,605
Property and equipment, net 5,190 4,517
Other non-current assets 10,258 3,572
Total assets [1] 338,488 379,694
Current liabilities:    
Accounts payable 2,564 4,946
Accrued and other current liabilities 10,090 13,859
Secured credit facilities and other debt, net 216,439 227,132
Secured credit facilities and other debt - related party 34,406 30,092
Total current liabilities 263,499 276,029
Warrant liabilities 122 471
Other long-term liabilities 10,154 1,418
Total liabilities [2] 273,775 277,918
Commitments and contingencies (Note 16)
Stockholders' equity:    
Additional paid in capital 507,431 499,660
Accumulated deficit (442,721) (397,887)
Total stockholders' equity 64,713 101,776
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY 338,488 379,694
Class A Common Stock    
Stockholders' equity:    
Common stock value $ 3 $ 3
[1] Our consolidated assets as of September 30, 2024 and December 31, 2023 include the following assets of certain variable interest entities (“VIEs”) that can only be used to settle the liabilities of those VIEs: Restricted cash, $9,922 and $3,867; Accounts receivable, $1,897 and $6,782; Real estate inventory, $256,472 and $276,500; Prepaid expenses and other current assets, $379 and $1,588; Total assets of $268,670 and $288,737, respectively.
[2] Our consolidated liabilities as of September 30, 2024 and December 31, 2023 include the following liabilities for which the VIE creditors do not have recourse to Offerpad: Accounts payable, $1,124 and $1,798; Accrued and other current liabilities, $1,595 and $2,027; Secured credit facilities and other debt, net, $250,845 and $257,224; Total liabilities, $253,564 and $261,049, respectively.